Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
Status
RECRUITING
Phase
NA
Age
≥ 18 Years
Enrollments
60Conditions
Prostate CancerSummary
The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.
Detailed Description
Primary Objectives:
The study objective is to increase the number of participants on prostate cancer clinical trials at LBJ. Investigators will complete several objectives:
* To design a culturally tailored video highlighting participant narratives and determine its impact on participants’ decision-making pertaining to joining a clinical trial
* To conduct educational sessions with frontline oncology providers
* To coordinate participant care through utilization of a nurse navigator
* To evaluate the effectiveness of this multi-pronged intervention to increase enrollment onto two prostate cancer clinical trials and compare enrollment and one-year retention rates before and after the intervention
Locations
1 location Found with status Recruiting
Status
- RECRUITING
Contact Person
- Debanjan Pain, MD
- 713-745-0075
- [email protected]
Principal Investigator
- Debanjan Pain, MD
Eligibility Criteria
Inclusion Criteria:
These criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who
Are eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period
Can provide informed consent.
Exclusion Criteria:
These criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.
Outcome Measures
Primary Outcome Measures
Safety and Adverse Events (AEs)
Timeline
Last Updated
June 26, 2026Start Date
May 18, 2026Today
October 1, 2026Completion Date ( Estimated )
January 31, 2030
Sponsors of this trial
Lead Sponsor
M.D. Anderson Cancer Center
RECRUITING 
≥ 18 Years